Kura Oncology, Inc.
Clinical-stage biopharma company developing precision medicines for cancer treatment.
KURA | US
Overview
Corporate Details
- ISIN(s):
- US50127T1097
- LEI:
- Country:
- United States of America
- Address:
- 4930 DIRECTORS PLACE, SUITE 500, 92121 SAN DIEGO
- Website:
- https://www.kuraoncology.com/
Description
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment. The company discovers and develops novel, targeted therapies designed to selectively inhibit cancer-driving molecular pathways. Its research is centered on creating small molecule drug candidates to address high unmet medical needs in various cancers, including acute leukemias, head and neck cancer, and lung cancer. Kura Oncology aims to provide patients with well-tolerated treatments that can achieve durable remissions, with a mission to help patients lead better and longer lives.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-04 13:30 |
10-Q - Kura Oncology, Inc. (0001422143) (Filer)
|
English | 1.6 MB |
Automate Your Workflow. Get a real-time feed of all Kura Oncology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kura Oncology, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kura Oncology, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
